SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ilaria Lesnoni La Parola, Carlo Cannistraci, Sara Izzi, Francesco Pisani, Ada Amantea, Franco Rongioletti, Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation, International Journal of Dermatology, 2014, 53, 10
  2. 2
    Javier Munoz, Filip Janku, Philip R. Cohen, Razelle Kurzrock, Erdheim-Chester Disease: Characteristics and Management, Mayo Clinic Proceedings, 2014, 89, 7, 985

    CrossRef

  3. 3
    Rayya A. Saadiq, Elizabeth B. Windgassen, 57-Year-Old Man With Flushing and Fainting, Mayo Clinic Proceedings, 2013, 88, 5, 527

    CrossRef

  4. 4
    J. Gotlib, A. Pardanani, C. Akin, A. Reiter, T. George, O. Hermine, H. Kluin-Nelemans, K. Hartmann, W. R. Sperr, K. Brockow, L. B. Schwartz, A. Orfao, D. J. DeAngelo, M. Arock, K. Sotlar, H.-P. Horny, D. D. Metcalfe, L. Escribano, S. Verstovsek, A. Tefferi, P. Valent, International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis, Blood, 2013, 121, 13, 2393

    CrossRef

  5. 5
    Juan Carlos Cardet, Cem Akin, Min Jung Lee, Mastocytosis: update on pharmacotherapy and future directions, Expert Opinion on Pharmacotherapy, 2013, 14, 15, 2033

    CrossRef

  6. 6
    Holly Martin, Raghuveer Singh Mali, Peilin Ma, Anindya Chatterjee, Baskar Ramdas, Emily Sims, Veerendra Munugalavadla, Joydeep Ghosh, Ray R. Mattingly, Valeria Visconte, Ramon V. Tiu, Cornelis P. Vlaar, Suranganie Dharmawardhane, Reuben Kapur, Pak and Rac GTPases promote oncogenic KIT–induced neoplasms, Journal of Clinical Investigation, 2013, 123, 10, 4449

    CrossRef

  7. 7
    Leonie K Ashman, Renate Griffith, Therapeutic targeting of c-KIT in cancer, Expert Opinion on Investigational Drugs, 2013, 22, 1, 103

    CrossRef

  8. 8
    Christoph Walz, Marion Subklewe, Hans-Peter Horny, Michael Flaig, Andreas Reiter, Thomas Kirchner, Karl Sotlar, Advanced systemic mastocytosis as a mimicker of metastatic clear cell renal cell carcinoma, Leukemia Research, 2012, 36, 6, 799

    CrossRef

  9. 9
    Tze S. Khor, Hiroshi Fujita, Koji Nagata, Michio Shimizu, Gregory Y. Lauwers, Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded, Journal of Gastroenterology, 2012, 47, 3, 226

    CrossRef

  10. 10
    Wolfgang R Sperr, Peter Valent, Diagnosis, progression patterns and prognostication in mastocytosis, Expert Review of Hematology, 2012, 5, 3, 261

    CrossRef

  11. 11
    Jessica Falleti, Ludovica Borgia, Anna Vittoria Lalinga, Rossella De Cecio, Valentina Natella, Giuseppe Patitucci, Giulia Vita, Mast cell sarcoma of the scalp: The first sign of undisclosed systemic mastocytosis?, Pathology - Research and Practice, 2012, 208, 11, 683

    CrossRef

  12. 12
    S. Takagi, Y. Saito, A. Hijikata, S. Tanaka, T. Watanabe, T. Hasegawa, S. Mochizuki, J. Kunisawa, H. Kiyono, H. Koseki, O. Ohara, T. Saito, S. Taniguchi, L. D. Shultz, F. Ishikawa, Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation, Blood, 2012, 119, 12, 2768

    CrossRef

  13. 13
    Celalettin Ustun, Natasha M. Savage, Jason Gotlib, Kapil Bhalla, Elizabeth Manaloor, Tracy I. George, Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: A case review, American Journal of Hematology, 2012, 87, 2
  14. 14
    Facharzt Hämatologie Onkologie, 2012,

    CrossRef

  15. 15
    J. Vardiman, E. Hyjek, World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm Variants, Hematology, 2011, 2011, 1, 250

    CrossRef